Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Change Of Heart - Dividends

<The future has two doors right now, MMP and PDSG, one needs a CEO, PTSC does not need a board or CEO!>

Well, you might be overlooking door number three. I keep thinking about whether Leckrone really wants out and whether TPL was/still is for sale. Then consider the appearance of a possible agreement between Moore and TPL and couple that with the fact that Moore has some new patents as well as pending applications. I think there is a door number three, just not sure what lurks behind it.

IF YOU'RE DRIVING ANYWHERE, PLEASE BE CAREFUL OUT THERE.

Blessed Christmas wishes to all. Opty

Share
New Message
Please login to post a reply